A flurry of new deals signed in the first quarter of 2014 are set to push up trade between Bahrain and India, while also paving the way for the Kingdom to continue expanding its health care sector and pharmaceuticals industry.
2013 saw the transition of power from the former Emir, Sheikh Hamad bin Khalifa Al Thani, to Sheikh Tamim bin Hamad Al Thani, his fourth son and second son with Sheikha Moza bint Nasser, a move unprecedented elsewhere in the Gulf but not unexpected in Qatar.
Articles & Analysis | Gradual overhaul: As Qatar's population ages, a state-led transformation is under way from The Report: Qatar 2014
Qatar’s health care sector is undergoing vigorous change, for both good and bad reasons. The good news is that Qataris are living longer. The bad is that more are living with lifestyle-related chronic diseases such as diabetes, heart disease and cancer. To meet this challenge, the government has been making sizeable investments in health care:...
Articles & Analysis | Farming pharmaceuticals: The government leads an effort to push generics over branded drugs from The Report: Qatar 2014
One beneficiary of the roll-out of Qatar’s new national health service will be the pharmaceutical industry. As part of the new health care system, the Supreme Council of Health (SCH) is leading an effort to promote generic drugs in partnership with Hamad Medical Corporation (HMC), the Primary Health Care Corporation (PHCC) and other providers....